R&D
R&D, East & West: Lilly invests in its global research network
July 10, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia, China, R&D, diabetes, lilly
Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …
Scinopharm Taiwan to build injectable drug facility
July 3, 2012Manufacturing and Production CMO, HPAPI, R&D, Scinopharm Taiwan
Contract manufacturing organisation Scinopharm Taiwan has said it plans to invest around $37.6 million in a new high-potency active pharmaceutical …
EMA publishes updated diabetes guidelines
July 2, 2012Research and Development, Sales and Marketing Avandia, EMA, GSK, R&D, Takeda
The European Medicines Agency has published new guidance on what it wants to see from firms submitting new diabetes treatments. …
Witty warns EU leaders over pricing
June 27, 2012Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing
Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …
Roche cuts 1,000 R&D jobs
June 27, 2012Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts
Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …
GSK partners with Cambridge University
June 18, 2012Research and Development, Sales and Marketing ABPI, Cambridge, GSK, R&D
The University of Cambridge begins a new collaboration with GlaxoSmithKline today to advance drug discovery and the development of new …
Merck Serono staff may strike over Geneva HQ closure
June 6, 2012Manufacturing and Production, Research and Development ASCO, Basel, Geneva, Merck Serono, Novartis, R&D
Workers at Merck Serono’s Swiss headquarters in Geneva have threatened industrial action over the company’s plans to shut down the …
Europe’s CMO market set to double by 2018, says F&S
May 30, 2012Manufacturing and Production CMO, Europe, F&S, R&D, Taylor, manufacturing
The European market for pharmaceutical contract manufacturing will double from a value of around $10 billion last year to almost …
GSK starts combination trial for melanoma
May 30, 2012Research and Development, Sales and Marketing GSK, R&D, Roche, Zelboraf, melanoma
GlaxoSmithKline has begun a combination trial for two of its investigational skin cancer drugs. The firm will combine dabrafenib, its …
Pharma R&D model no help to developing countries
May 22, 2012Research and Development, Sales and Marketing HIV, MSF, Médecins Sans Frontières, R&D
Médecins Sans Frontières is urging health ministers around the world to create an ‘R&D Convention’ to ensure that pharma helps …
UCB signs new epilepsy research pact with Imperial
May 21, 2012Research and Development, Sales and Marketing R&D, Scotland, UCB, epilepsy
UCB has signed a two-year research deal with Imperial College London to find disease-modifying targets in epilepsy. The firm has …
Merck KGaA sets out savings target as staff threaten to strike
May 15, 2012Research and Development, Sales and Marketing Merck KGaA, R&D, Serono, cuts
Merck KGaA has outlined its plan to make €300 million in savings from its Serono drugs unit, with over half …
GlaxoSmithKline to acquire Cellzome for £61 million
May 15, 2012Research and Development, Sales and Marketing Cellzome, Domantis, GSK, R&D
GlaxoSmithKline will expand its platform technology capability with the acquisition of a chemical proteomics company. GSK will acquire those shares …
Teva appoints new president of R&D
May 9, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Hayden, R&D, Teva
Teva has appointed Dr Michael Hayden as its new president of global R&D and chief scientific officer at the firm’s …
Takeda to buy gout specialist URL Pharma for $800m
April 16, 2012Research and Development, Sales and Marketing R&D, Takeda, acquisition, gout
Takeda is set to purchase URL Pharmaceuticals for $800 million, helping offset the loss of its blockbuster ulcer drug Prevacid. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
